Clinical Trial Update: PET-MR-PSA Prostate Cancer Recidive Study

View source ↗

Summary

The PET-MR-PSA Prostate Cancer Recidive trial is currently active but not recruiting, focusing on imaging for recurrent prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Norwegian University of Science and Technology | Conditions: Prostate Cancer Recurrent | Status: ACTIVE_NOT_RECRUITING